Immunocore Reports Second Quarter Financial Results And Provides A Business Update

Refinitiv阅读少于1分钟

Immunocore Holdings PLC IMCR:

IMMUNOCORE REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
IMMUNOCORE : PHASE 3 TEBE-AM TRIAL REMAINS ON SCHEDULE TO COMPLETE ENROLLMENT IN THE FIRST HALF OF 2026
IMMUNOCORE : KIMMTRAK®(TEBENTAFUSP-TEBN) NET REVENUES OF $98.0 MILLION IN Q2 2025

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

登录或创建永久免费帐户以阅读此新闻